Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures

AIDS

Volumn 23, Issue 6, 2009, Pages 701-706

  Bicanic, Tihana ^a,b,c   Brouwer, Annemarie E ^b,d,g   Meintjes, Graeme ^a,c   Rebe, Kevin ^a,c   Limmathurotsakur, Direk ^d   Chierakul, Wirongrong ^d   Teparrakkul, Praprit ^e   Loyse, Angela ^a,b,c   White, Nicholas J ^d,f   Wood, Robin ^a   Jaffar, Shabbar ^h   Harrison, Thomas ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c Infectious Diseases Unit   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e Sappasitthiprasong Hospital   (Thailand)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cerebrospinal fluid pressure; Cryptococcal meningitis; Cryptococcus; HIV; Lumbar puncture; Raised intracranial pressure

Indexed keywords

AMPHOTERICIN B; CYTOKINE; FLUCONAZOLE;

ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FUNGUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFUSION REACTION; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MENTAL HEALTH; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SOUTH AFRICA; SYMPTOM; THAILAND;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID PRESSURE; COMBINED MODALITY THERAPY; CRYPTOCOCCUS; HUMANS; INTRACRANIAL HYPERTENSION; MENINGITIS, CRYPTOCOCCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SPINAL PUNCTURE; TREATMENT OUTCOME;

EID: 64549108540     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832605fe     Document Type: Article

References (16)

1. Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker LG, et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretrovir- al-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 2007; 45:76-80.
2. Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006; 20:2183-2191.
3. Bicanic T, Wood R, Meintjes G, Rebe K, Brouwer A, Loyse A, et al. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis 2008; 47:123-130.
4. Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991; 91:267-272.
5. Hussey F, Schanzer B, Katzman R. A simple constant-infusion manometric test for measurement of CSF absorption. II: Clinical studies. Neurology 1970; 20:665-680.
6. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000; 30:47-54.
7. Macsween KF, Bicanic T, Brouwer AE, Marsh H, Macallan DC, Harrison TS. Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review. J Infect 2005; 51:e221-e224.
8. Rex JH, Larsen RA, Dismukes WE, Cloud GA, Bennett JE. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine (Baltimore) 1993; 72:207-224.
9. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Pow-derly WG, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000; 30:710-718.
10. Fessler RD, Sobel J, Guyot L, Crane L, Vazquez J, Szuba MJ, et al. Management of elevated intracranial pressure in patients with Cryptococcal meningitis. J Acquit Immune Defic Syndr Hum Retrovirol 1998; 17:137-142.
11. Shoham S, Cover C, Donegan N, Fulnecky E, Kumar P. Cryptococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of healthcare providers to published practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2005; 40:477-479.
12. Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, et al. Combination antifungal therapies for HIV- associated cryptococcal meningitis: a randomised trial. Lancet 2004; 363:1764-1767.
13. Shelburne SA III, DarcourtJ, White AC Jr, GreenbergSB, Hamill RJ, Atmar RL, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:1049-1052.
14. Siddiqui A, Brouwer AE, Suprapada P, Wuthiekanun V, Jaffar S, Shattock R, et al. Interferon-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol 2005; 174:1746-1750.
15. Manosuthi W, Sungkanuparph S, Chottanapund S, Tansuphas- wadikul S, Chimsuntorn S, Limpanadusadee P, et al. Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis. Int J Std AIDS 2008; 19:268-271.
16. Fries BC, Lee SC, Kennan R, Zhao W, Casadevall A, Goldman DL. Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infect Immun 2005; 73:1779-1787.